Reducing the risk of developing cardiovascular disease for people with diabetes

The ACCORD Study Group results summary:

1. Effective blood pressure control does not reduce CVD risk in people with type 2 diabetes at high risk for CVD.

2. A combination of a statin and a fibrate was no better at reducing risk than a statin alone in patients with type 2 diabetes at high risk for CVD.

3. For patients with low HDL and low triglycerides, the combination lipid therapy may be successful in reducing CVD risk in those with type 2 diabetes patients.

The ACCORD Study Group – New England Journal of Medicine, March 14,2010; N Engl J Med 2010;362:1575-85. N Engl J Med 2010; 362:1563-74. www.nejm.org;